NYSE
RYL

The Ryland Group, Inc.

Shareholder Corporation Litigation

Rigrodsky & Long, P.A. Announces Investigation Of The Ryland Group, Inc. (NYSE: RYL) Merger

Rigrodsky & Long, P.A. announces that it is investigating potential legal claims against the board of directors of The Ryland Group, Inc. (“Ryland” or the “Company”) (NYSE: RYL) regarding possible breaches of fiduciary duties and other violations of law related to the Company’s entry into an agreement to merge with Standard Pacific Corp. (“Standard Pacific”) (NYSE: SPF).

Under the terms of the agreement, Ryland shareholders will receive 1.0191 shares of Standard Pacific common stock for each share of Ryland common stock (which would be 5.0957 shares prior to giving effect to the announced 1 for 5 reverse stock split).  Upon closing of the transaction, Standard Pacific stockholders will own approximately 59% and Ryland shareholders will own approximately 41% of the combined company.

The investigation concerns whether Ryland’s board of directors failed to adequately shop the Company and obtain the best possible value for Ryland’s shareholders before entering into an agreement with Standard Pacific.

If you own the common stock of Ryland and purchased your shares before June 15, 2015, if you have information or would like to learn more about these claims, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Seth D. Rigrodsky or Gina M. Serra at Rigrodsky & Long, P.A., 2 Righter Parkway, Suite 120, Wilmington, DE 19803, by telephone at (888) 969-4242; by e-mail to info@rl-legal.com.

Rigrodsky & Long, P.A., with offices in Wilmington, Delaware and Garden City, New York, regularly prosecutes securities class, derivative and direct actions, shareholder rights litigation and corporate governance litigation, on behalf of shareholders in states and federal courts throughout the United States.

Attorney advertising.  Prior results do not guarantee a similar outcome.